Humana Inc. (HUM) Upgraded to Equal-Weight at Morgan Stanley

Market Context

Humana Inc. operates in the Healthcare sector. The stock currently trades at $365.23 with a market capitalization of $32.0B. The stock has gained 58.2% over the past 52 weeks.

Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. Morgan Stanley's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Humana Inc.

Among the 10 most recent ratings: 3 Buy, 7 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Aug 05, 2026	Morgan Stanley	Equal-Weight	N/A
Jul 31, 2026	TD Cowen	Hold	N/A
Jul 31, 2026	Barclays	Equal-Weight	N/A
Jul 30, 2026	Guggenheim	Buy	N/A
Jul 30, 2026	Evercore ISI Group	Outperform	N/A

Related Tools: Analyst Ratings Dashboard | View HUM Stock Page